Searchable News & Info From Reliable Online Sources.
- DoorDash now accepts SNAP benefits at Kroger stores
Delivery fees are waived on first orders from the grocer [TheTopNews] Read More.23 mins ago - Consumer product safety recall roundup for May 1, 2026
Thermoses, baby toys, furniture, and more are part of this week's recalls By News Desk of ConsumerAffairs May 1, 2026 Recent notices from the CPSC, FDA and USDA FSIS cover everything from food containers and childrens products to medical fluids and salmonella-related food alerts. Thermos jars and bottles can eject stoppers Thermos is recalling about 8.2 million containers after reports that pressure can build inside and launch the stopper when opened. If perishable food or drinks sit in the container too long, the stopper can forcefully eject and cause serious impact and laceration injuries. About 5.8 million Stainless King Food Jars and 2.3 million Sportsman Food & Beverage Bottles were sold nationwide and online between 2008 and 2024. Consumers should stop using the recalled containers immediately and contact Thermos for a replacement stopper or replacement bottle. Thermos L.L.C., of Schaumburg, Illinois, is recalling Stainless King Food Jars with model numbers SK3000 and SK3020 made before July 2023, along with all Sportsman Food & Beverage Bottles with model number SK3010. The stainless containers were sold in multiple colors and sizes, and the Thermos trademark appears on the side while the model number is printed on the bottom. The company said the recalled stoppers do not have a pressure relief in the center. The hazard Pressure can build up if perishable food or beverages are stored in the container for an extended period. When the consumer opens it, the stopper can shoot out with force, creating serious impact and laceration hazards. Thermos has received 27 reports of consumers being struck by an ejected stopper, including injuries that required medical attention. Three consumers suffered permanent vision loss after being hit in the eye. What to do Consumers should stop using the recalled food jars and bottles immediately. Thermos is offering a free replacement pressure-relief stopper for the recalled SK3000 and SK3020 food jars and a replacement bottle for the recalled SK3010 bottles. For the food jars, consumers will be asked to throw away the stopper and send Thermos a photo of the disposed stopper. For the recalled bottle, consumers will be asked to return it using a prepaid shipping label. Company contact Thermos says consumers can get help online at https://support.thermos.com or through https://www.thermos.com by clicking Contact Us or Recall Info, or by calling 662-563-6822 from 7 a.m. to 3:30 p.m. CT Monday through… [TheTopNews] Read More.31 mins ago - ‘Mr. Nobody Against Putin’ Director’s Oscar Is Found After Airline Lost It
Pavel Talankin, a co-director and star of the documentary “Mr. Nobody Against Putin,” was told by T.S.A. agents that his Academy Award could be used as a weapon. [TheTopNews] Read More.34 mins ago - Can food be medicine? A new study tests the idea in heart failure patients
Experts say better food choices can improve long-term quality of life By Kristen Dalli of ConsumerAffairs May 1, 2026 A clinical trial tested whether delivering healthy food helps people recover after heart failure hospitalization. The program was highly feasible, with strong participation and satisfaction among patients. While it didnt reduce hospital visits, patients reported meaningful improvements in quality of life. The idea that food can play a role in medical care has been gaining traction but how well does it actually work in real life? A new clinical trial led by UT Southwestern Medical Center set out to answer that question in people recovering from heart failure, a condition affecting millions of Americans. After leaving the hospital, many patients face a tough transition. Managing medications, following dietary guidelines, and accessing healthy food can all be challenging especially for those experiencing food insecurity. Researchers wanted to know whether directly providing nutritious food could help. Their approach sometimes called food as medicine focused on giving patients the tools and resources to eat better during a critical recovery window. This was designed as a pilot trial to answer a very practical question: Can we actually deliver food-as-medicine interventions to patients in the vulnerable period after a heart failure hospitalization and will patients accept them? researcher Ambarish Pandey, M.D. said in a news release. What we showed is that this approach is not only feasible, but patients also really valued it. How the study worked The trial included 150 patients who had recently been hospitalized for heart failure at two hospitals in Dallas between April 2024 and October 2025. Participants were enrolled within two weeks of discharge and followed for 90 days. They were randomly assigned to one of three groups: one received medically tailored meals designed by dietitians, another received boxes of fresh produce along with recipes, and a third group received standard care with dietary counseling alone. Among those receiving food support, researchers also tested whether tying deliveries to behaviors like attending clinic visits or filling prescriptions made a difference. The study tracked several outcomes, including how consistently food was delivered, how much participants used it, and whether it affected hospital readmissions or emergency department visits. Researchers also measured quality of life using a standardized questionnaire. What the researchers found Overall, the program proved highly workable. More than 90% of food deliveries… [TheTopNews] Read More.38 mins ago - Common IBS treatments may carry hidden long-term risksLarge U.S. study finds small but notable mortality link By Kristen Dalli of ConsumerAffairs May 1, 2026 A large U.S. study found some IBS medications are linked to a higher risk of death over time. Antidepressants and certain antidiarrheal drugs showed the strongest associations. Researchers stress the overall risk remains small and not cause-and-effect. For millions of Americans living with irritable bowel syndrome (IBS), daily symptom management often means relying on medication. But a new large-scale study is raising questions about how safe some of those treatments are over the long haul. Researchers from Cedars-Sinai examined commonly used IBS medications and found that some may be associated with a small but measurable increase in the risk of death. While that might sound alarming, experts emphasize that the overall risk for any one person remains low. Many patients are diagnosed with IBS at a young age and may remain on medications for years, researcher Ali Rezaie, M.D. said in a news release However, most clinical trials of these medications last less than a year, so we know very little about their long-term safety. This study begins to address that gap. How the study was conducted To better understand long-term safety, researchers analyzed nearly two decades of electronic health records from more than 650,000 adults in the United States diagnosed with IBS. This makes it the largest real-world study of its kind. The team compared patients taking different types of IBS treatments, including FDA-approved medications, antidepressants, antispasmodics, and opioid-based antidiarrheal drugs like loperamide and diphenoxylate. Using this large dataset, researchers evaluated how these medications were associated with all-cause mortality over time. Importantly, the study was observational, meaning it looked at patterns in existing data rather than testing medications in a controlled trial. That distinction matters: the findings show associations, not proof that the drugs directly cause harm. What the researchers found The results revealed clear differences between medication types. Long-term use of antidepressants was associated with about a 35% higher risk of death compared to non-use. Meanwhile, two commonly used antidiarrheal drugs loperamide and diphenoxylate were linked to roughly double the risk. On the other hand, several other treatments did not show this association. Antispasmodics and certain FDA-approved IBS medications were not linked to increased mortality risk. Researchers also noted that the increased risk may be tied to higher rates of serious health… [TheTopNews] Read More.47 mins ago
- Why vapes are becoming a bigger risk for young kidsNew data shows nicotine dangers are shifting inside homes By Kristen Dalli of ConsumerAffairs May 1, 2026 A new study found nicotine exposures from cigarettes declined in young children, while vape-related incidents rose sharply. Researchers reviewed more than 92,000 poison control reports involving children age 5 and younger. Unlike cigarettes, many recent vape exposures involved children directly inhaling from devices. For years, cigarettes were considered one of the biggest nicotine-related hazards for young children at home. But a new study suggests that risk is changing as vaping devices become more common. Researchers found that while traditional tobacco exposures among young children have been declining, incidents involving e-cigarettes are rising quickly instead. The concern isnt just that children are getting into nicotine products its how theyre being exposed. Unlike traditional cigarettes, which often involve accidental ingestion or contact, many newer cases linked to e-cigarettes involve children actually inhaling from the devices. Because many vapes are colorful, compact, and easy to activate, researchers say they may be more accessible and more appealing to curious young children. "This significant spike in children breathing in these substances tells us the risk has changed: Its no longer just about a toddler swallowing something they found on the floor, researcher Perry Rosen said in a news release. Many recent cases involve children actively using e-cigarette devices after gaining access to them. How the study worked Researchers from the New Jersey Poison Control Center analyzed reports from the National Poison Data System, a database that collects poison exposure cases from across the United States. The team looked specifically at nicotine exposure reports involving children age 5 and younger between 2016 and 2023. In total, the study included more than 92,000 reported exposures. The researchers compared different types of nicotine products, including conventional tobacco products such as cigarettes, as well as newer products like disposable e-cigarettes and nicotine pouches. Their goal was to better understand how childrens nicotine exposure risks have changed as the nicotine product landscape has evolved. According to the study, this was the first analysis to examine exposure trends across all nicotine product categories in young children over this time period. What researchers found The study found that exposures involving conventional tobacco products dropped by 43% during the study period. At the same time, incidents involving e-cigarettes increased by 243%. Researchers also found that children exposed… [TheTopNews] Read More.50 mins ago
- Harris Teeter carries more GLP-1 med weightThe grocer expands range and offers nutrition support [TheTopNews] Read More.53 mins ago
The Searchable USWebDaily.com and TheTopNews NewsBank Helps You Be Better Informed, Faster! Spread The Word.
